Report cover image

InspireMD Inc (NSPR) - Product Pipeline Analysis, 2025 Update

Publisher GlobalData
Published Feb 16, 2026
Length 37 Pages
SKU # GBDT20881298

Description

Summary

InspireMD Inc (InspireMD) is a medical device company that develops and commercializes embolic prevention systems and neurovascular devices. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, acute myocardial infarction and saphenous vein graft coronary intervention. It utilizes MicroNet stent platform technology to develop its products and offers solutions for various disease conditions such as stenting, embolic showers, restenosis and late stent thrombosis. The company markets its products through a network of distributors in Israel and Germany. InspireMD is headquartered in Tel Aviv, Israel.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company InspireMD Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company

Table of Contents

37 Pages
InspireMD Inc Company Overview
InspireMD Inc Company Snapshot
InspireMD Inc Pipeline Products and Ongoing Clinical Trials Overview
InspireMD Inc – Pipeline Analysis Overview
InspireMD Inc - Key Facts
InspireMD Inc - Major Products and Services
InspireMD Inc Pipeline Products by Development Stage
InspireMD Inc Ongoing Clinical Trials by Trial Status
InspireMD Inc Pipeline Products Overview
CGuard Embolic Prevention System
CGuard Embolic Prevention System Product Overview
CGuard Embolic Prevention System Clinical Trial
MGuard Drug Eluting Stent
MGuard Drug Eluting Stent Product Overview
Next Gen CGuard - 5F
Next Gen CGuard - 5F Product Overview
Next Generation Delivery System
Next Generation Delivery System Product Overview
NGuard
NGuard Product Overview
PVGuard Peripheral
PVGuard Peripheral Product Overview
RGuard Renal
RGuard Renal Product Overview
SwitchGuard Neuroprotection System
SwitchGuard Neuroprotection System Product Overview
SwitchGuard Neuroprotection System Clinical Trial
InspireMD Inc - Key Competitors
InspireMD Inc - Key Employees
InspireMD Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
InspireMD Inc, Recent Developments
Jan 12, 2026: InspireMD Announces Publication of the C-GUARDIANS Pivotal Trial Manuscript in the Journal of the American College of Cardiology (JACC)
Dec 19, 2025: InspireMD Announces Board Changes
Nov 24, 2025: Landmark CREST-2 Study Published in the New England Journal of Medicine Highlights the Benefits of Carotid Artery Stenting
Nov 04, 2025: InspireMD Reports Third Quarter 2025 Financial Results
Nov 03, 2025: InspireMD Appoints Peter A. Soukas, M.D., as Chief Medical Officer
Sep 17, 2025: InspireMD Appoints Dan Dearen to Board of Directors
Jul 09, 2025: Inspiremd Announces U.S. Commercial Launch of CGuard Prime Carotid Stent System for the Prevention of Stroke
Jul 09, 2025: InspireMD Obtains PMA Approval for CGuard Prime Carotid Stent System
Jun 24, 2025: InspireMD Announces FDA Approval for CGuard Prime Carotid Stent System for the Prevention of Stroke
Jun 16, 2025: InspireMD's embolic prevention system gains CE Mark approval
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
InspireMD Inc Pipeline Products and Ongoing Clinical Trials Overview
InspireMD Inc Pipeline Products by Equipment Type
InspireMD Inc Pipeline Products by Indication
InspireMD Inc Ongoing Clinical Trials by Trial Status
InspireMD Inc, Key Facts
InspireMD Inc, Major Products and Services
InspireMD Inc Number of Pipeline Products by Development Stage
InspireMD Inc Pipeline Products Summary by Development Stage
InspireMD Inc Ongoing Clinical Trials by Trial Status
InspireMD Inc Ongoing Clinical Trials Summary
CGuard Embolic Prevention System - Product Status
CGuard Embolic Prevention System - Product Description
CGuard Embolic Prevention System - Acute Stroke of Carotid Artery Bifurcation Origin Treated with Use of the Micronet-covered CGUARD Stent Under Transient Flow Reversal Linked with Thrombus Retrieval: SAFEGUARD-STROKE Study
CGuard Embolic Prevention System - An Early Feasibility Study (EFS) Assessing the CGuard Embolic Prevention Carotid Stent to Treat Severe Carotid Stenosis or Occlusion
CGuard Embolic Prevention System - Long-term Outcomes of MicroNet-covered Stent Routine Use for Stroke Prevention in Symptomatic and Increased-risk Asymptomatic Carotid Stenosis Patients Requiring Revascularization by Neurovascular Team Decision: PARADIGM-EXTEND
CGuard Embolic Prevention System - OPTIMAl Endovascular Exclusion of High-risk Carotid Plaque Using the CGuard Stent in Patients with Symptoms or Signs of Carotid Stenosis-related Brain Injury: IVUS Controlled Investigator Initiated Multcentric Multi-specialty Study
MGuard Drug Eluting Stent - Product Status
MGuard Drug Eluting Stent - Product Description
Next Gen CGuard - 5F - Product Status
Next Gen CGuard - 5F - Product Description
Next Generation Delivery System - Product Status
Next Generation Delivery System - Product Description
NGuard - Product Status
NGuard - Product Description
PVGuard Peripheral - Product Status
PVGuard Peripheral - Product Description
RGuard Renal - Product Status
RGuard Renal - Product Description
SwitchGuard Neuroprotection System - Product Status
SwitchGuard Neuroprotection System - Product Description
SwitchGuard Neuroprotection System - A Multicenter, Single-arm, Pivotal Study to Evaluate the Safety and Efficacy of the SwitchGuard Neuroprotection System (NPS) for Providing Cerebral Embolic Protection During Carotid Artery Stenting Via the Transcarotid Artery Revascularization (TCAR) Approach When Used in Conjunction With the CGuard Prime 80 Carotid Stent System
SwitchGuard Neuroprotection System - A Study to Evaluate the Efficacy of SwitchGuard Neuroprotection System in Transcarotid Artery Revascularization Procedures
InspireMD Inc, Key Employees
InspireMD Inc, Other Locations
Glossary
List of Figures
InspireMD Inc Pipeline Products by Equipment Type
InspireMD Inc Pipeline Products by Development Stage
InspireMD Inc Ongoing Clinical Trials by Trial Status

Search Inside Report

How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.